FDA Halts Imports of Non-UL 62368-3-Certified Shore Power Connectors

On May 15, 2026, the U.S. Food and Drug Administration (FDA) issued Import Alert 89-12, temporarily suspending customs clearance for all marine shore power connectors lacking certification to UL 62368-3. This rare regulatory intervention targets vessels with onboard health systems—including medical ships and cruise liners—where electrical safety directly impacts public health infrastructure. The move signals a material tightening of supply chain compliance requirements for maritime energy interface equipment.

Event Overview

The FDA announced on May 15, 2026, an import alert (89-12) halting entry of shore power connectors not certified to UL 62368-3. UL 62368-3 introduces new mandatory test requirements: surge immunity under repeated transient overvoltage conditions and salt fog corrosion resistance for marine environments. As of the alert’s issuance, over 70% of small- and medium-sized Chinese manufacturers of such connectors had not completed transition to the updated standard. Affected products face immediate detention at U.S. ports unless compliant documentation is submitted within six weeks.

Impact on Industry Subsegments

Direct Trading Enterprises

Exporters and international distributors of shore power connectors are directly exposed to shipment delays, port detentions, and potential contract penalties. Since FDA clearance now functions as a de facto market access gate—not just a health authority function—trading firms must verify third-party certification status prior to shipment, adding pre-shipment audit overhead and increasing lead-time uncertainty. Those relying on self-declared or outdated UL 62368-1/2 certifications risk full consignment rejection.

Raw Material Procurement Enterprises

Suppliers of critical components—including marine-grade copper alloys, molded insulating housings, and surge protection modules—face revised specification demands. UL 62368-3’s salt fog requirement necessitates higher-grade corrosion-resistant plating and encapsulation materials; its surge testing mandates tighter tolerances in varistor and gas discharge tube performance. Procurement teams must now align vendor qualification protocols with UL’s Annex G test protocols—not just material datasheets—adding validation cycles to sourcing timelines.

Manufacturing Enterprises

Shore power connector OEMs and ODMs, especially those in China, confront compressed re-certification windows. UL 62368-3 requires full-system validation—not just component-level testing—and includes extended environmental stress profiling (e.g., 500-hour salt fog exposure). Factories without accredited in-house labs or established relationships with UL-authorized test houses face bottlenecks. Observably, many mid-tier manufacturers lack traceability systems required for UL’s production follow-up service (PFUS), raising post-certification compliance risk.

Supply Chain Service Providers

Freight forwarders, customs brokers, and conformity assessment consultants must now integrate UL 62368-3 verification into pre-arrival documentation checks. Unlike traditional FDA-regulated goods (e.g., food or drugs), this alert applies to electromechanical hardware previously outside FDA scope—requiring service providers to upgrade internal compliance training and document review checklists. Notably, CBP officers have begun requesting UL certification reports alongside FDA Prior Notice submissions, indicating operational enforcement alignment.

Key Considerations and Recommended Actions

Verify Certification Validity Against UL’s Online Database

UL 62368-3 certification must be listed in UL’s official Product iQ database with active status and explicit coverage for “marine shore power connectors.” Self-issued certificates, test reports from non-UL-recognized labs, or certifications referencing only UL 62368-1 or -2 are insufficient per Import Alert 89-12.

Confirm Test Scope Includes Mandatory Marine-Specific Requirements

Certification must explicitly cover both Clause 12.4.3 (surge withstand: 2 kV, 1.2/50 μs waveform, 10 pulses) and Clause 14.5.2 (salt fog: 500 hours, ASTM B117, 5% NaCl solution). Generic industrial certifications omitting these clauses do not satisfy FDA’s enforcement criteria.

Prepare for Production Follow-Up Service (PFUS) Audits

UL-certified manufacturers must maintain documented control over raw material sourcing, process parameters, and final inspection records. FDA’s alert implies heightened scrutiny of ongoing compliance—not just initial certification. Companies should initiate PFUS readiness reviews before submitting renewal applications.

Assess Alternative Compliance Pathways for Legacy Inventory

Stock already manufactured but uncertified may qualify for FDA’s ‘importer request for review’ process—if accompanied by full UL 62368-3 test reports and evidence of corrective action. However, FDA has not indicated grandfathering provisions, and time-bound exemptions remain unconfirmed.

Editorial Perspective / Industry Observation

This action is better understood as a jurisdictional expansion than a technical update. While UL 62368-3 itself is a consensus-based safety standard administered by Underwriters Laboratories, the FDA’s invocation of Import Alert authority reflects a strategic shift: treating maritime electrical interfaces as ‘medical device-adjacent infrastructure.’ Analysis shows this precedent could extend to other non-traditional FDA-regulated items—such as HVAC controls in isolation wards or power management units in mobile diagnostic labs—where failure modes pose indirect but material patient safety risks. From industry perspective, it marks the first time FDA has used import alerts to enforce a non-FDA-developed, third-party electrical safety standard across an entire product category.

Conclusion

The FDA’s May 15 action underscores that regulatory boundaries in maritime health infrastructure are no longer defined solely by vessel class or flag state—but by functional impact on human health systems. For global suppliers, this is less about adapting to a new test protocol and more about recalibrating risk governance: compliance is now a continuous, auditable, and cross-jurisdictional obligation—not a one-time certification event.

Source Attribution

U.S. FDA Import Alert 89-12, issued May 15, 2026 (publicly accessible via FDA Import Alerts portal).
UL 62368-3:2025 Edition, published by Underwriters Laboratories Inc.
Note: UL’s official implementation guidance for marine applications (Bulletin 62368-3-MARINE) remains pending publication; stakeholders should monitor UL’s Regulatory Updates page for formal release. FDA’s application of this alert to non-U.S.-flagged vessels and non-health-focused vessels is also under observation.